Eli Lilly Houston Processing Campus

Houston, Texas

The Eli Lilly Houston Processing Campus is a $6.5 billion pharmaceutical manufacturing facility under construction at Generation Park in Houston, Texas. Spanning 236 acres, the project will produce active pharmaceutical ingredients (APIs) for Eli Lilly’s portfolio, including diabetes and weight-loss drugs. It is the largest for-profit life sciences investment in Texas history, expected to create over 615 full-time jobs and 4,000 construction jobs. The campus is currently under construction, with completion targeted for 2030.